GH insider reports 13,550 RSUs vesting and a $62.65 purchase
Rhea-AI Filing Summary
Chris Freeman, Chief Commercial Officer of Guardant Health, Inc. (GH), reported multiple equity transactions dated 10/01/2025. He had 13,550 restricted stock units vest or be credited (1,928; 1,668; 9,954) and a separate purchase of 5,740 shares at $62.65. The company retained 5,740 shares to satisfy the tax withholding related to one vesting installment; the filer notes the retained amount did not exceed the tax liability. Following the reported transactions, Freeman beneficially owned 63,179 shares (direct ownership). The Form 4 was signed by an attorney-in-fact on behalf of Mr. Freeman on 10/02/2025.
Positive
- Insider increased direct ownership to 63,179 shares through vesting and purchase
- Market purchase of 5,740 shares at $62.65 shows insider added shares with personal funds
- Tax withholding executed by the company was limited to the tax liability (no excess withholding)
Negative
- None.
Insights
Multiple RSU vesting plus a market purchase increases direct insider ownership.
The filing shows 13,550 restricted stock units vesting in three separate awards and a purchase of 5,740 shares at $62.65 on 10/01/2025. Vesting and purchases both increase the reporting person’s direct holdings to 63,179 shares.
The company withheld 5,740 shares to meet tax obligations related to vesting and explicitly states the withheld amount was not in excess of the tax liability.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 1,928 | $0.00 | -- |
| Exercise | Restricted Stock Units | 1,668 | $0.00 | -- |
| Exercise | Restricted Stock Units | 9,954 | $0.00 | -- |
| Exercise | Common Stock | 1,928 | $0.00 | -- |
| Exercise | Common Stock | 1,668 | $0.00 | -- |
| Exercise | Common Stock | 9,954 | $0.00 | -- |
| Tax Withholding | Common Stock | 5,740 | $62.65 | $360K |
Footnotes (1)
- These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter. Not applicable for Restricted Stock Units. This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vests on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
